In previous studies, Zhang et al. [51] found that UDCA administration ameliorates metabolic dysfunction in mice with HFD-induced mice, and Pathil et al. [52] determined that UDCA-conjugated phospholipids alleviate serum ALT levels in HFD- and MCD-induced liver injury in mice. The gene discussed is GPT; the disease is injury.